Tarsus Pharmaceuticals
The Director, Early Development - Clinical Sciences will design and lead early development clinical plans, oversee study execution, and ensure scientific rigor across cross‑functional teams. This role involves authoring key regulatory documents, guiding investigators, and collaborating with operations, regulatory, medical, and other functions to drive efficient early‑stage clinical programs.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
5% above the average for this role
Director, Clinical Development – EMEAI
oraclecloudinfrastructure
Associate Director, Clinical Scientist
Madrigal Pharmaceuticals
Director, Clinical Development
Avalyn Pharma
Senior Clinical Scientist
Arcus Biosciences
Associate Medical Director, Early Development
Vertex
Associate Medical Director, Clinical Development
Tonix Pharmaceuticals